2024-03-04 16:44:51 ET
DENVER, Colo., Mar 04, 2024 ( 247marketnews.com )- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO ) reported, after today’s market close, financial results for the quarter and full year ended December 31, 2023.
Ekso Bionics is trading at $2.2101, up $0.1101 (+5.24%), on 1.8M afterhours shares.
Ekso Bionics sold a total of 151 EksoHealth units in 2023 full year and achieved record revenue of $18.3 million for the 2023 full year, a 42% year-over-year increase.
“We are excited to have closed 2023 with record revenues driven by strong demand for our EksoHealth devices and expanded offerings across the continuum of care from hospital to home,” said Scott Davis, Chief Executive Officer of Ekso Bionics. “In support of our mission, we remain focused on expanding the reach of our exoskeleton devices to patients who can benefit the most. We believe the combination of our robust exoskeleton portfolio and the positive traction of our scalable commercial strategy position us well to drive long-term growth.”
The post Ekso Bionics Reports Q4 and FY Financials Including Record Annual Revenue appeared first on 24/7 MarketNews .
For further details see:
Ekso Bionics Reports Q4 and FY Financials Including Record Annual Revenue